Search

Search Constraints

You searched for: Author/Creator Spicer, James F.

Search Results

1. AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody. Issue 10 (27th May 2019)

2. Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs). (4th March 2018)

3. Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate. Issue 8 (10th March 2020)

4. CAR T-cell immunotherapy of MET-expressing malignant mesothelioma. (2nd December 2017)

5. Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action. Issue 3 (23rd February 2021)

6. Development of downstream processing to minimize beta‐glucan impurities in GMP‐manufactured therapeutic antibodies. (21st October 2016)

8. Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma. (3rd June 2019)

9. In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model. Issue 1 (1st January 2020)

10. Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells. (1st May 2017)